Compound Info | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NAs | Base Info | ||||||||||||
ID | Cluster | Name | Target | MolWt | |||||||||
![]() |
NAs.001807 | 7 |
|
382.207 |
Chemical Representations | |
---|---|
InChI | InChI=1S/C15H13Cl2N5O3/c1-20-13-12(14(24)21(2)15(20)25)22(7-18-13)6-11(23)19-10-4-3-8(16)5-9(10)17/h3-5,7H,6H2,1-2H3,(H,19,23) |
InChI Key | BHFSERMJVJNWHL-UHFFFAOYSA-N |
SMILES | Cn1c(=O)c2c(ncn2CC(=O)Nc2ccc(Cl)cc2Cl)n(C)c1=O |
Molecular Formula | C15H13Cl2N5O3 |
Functional Fragments | ||
---|---|---|
Base | Ribose | Phosphate |
![]() Match
|
![]() Match
|
![]() |
Calculated Properties | ||
---|---|---|
logP | 1.379 | Computed by RDKit |
Heavy Atom Count | 25 | Computed by RDKit |
Ring Count | 3 | Computed by RDKit |
Hydrogen Bond Acceptor Count | 7 | Computed by RDKit |
Hydrogen Bond Donor Count | 1 | Computed by RDKit |
Rotatable Bond Count | 3 | Computed by RDKit |
Topological Polar Surface Area | 90.920 | Computed by RDKit |
Activity Data | ||||||
---|---|---|---|---|---|---|
Target | Activity type | Relation | Value | Unit | Assay | Source |
DNA polymerase beta | Potency | = | 1584.9 | nM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | CHEMBL1201862 |
Plasmodium falciparum | Potency | 18526.0 | nM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | CHEMBL1201862 | |
Unchecked | Potency | 31622.8 | nM | PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) | CHEMBL1201862 | |
Guanine nucleotide-binding protein G(s), subunit alpha | Potency | 35481.3 | nM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | CHEMBL1201862 |